P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847836.30971.66 |
| _version_ | 1797281113590202368 |
|---|---|
| author | D. Zhou X. Huang X. Li L. Zhu M. Xie X. Huang L. Ma X. Yang J. Sun L. Li J. Zhu X. Zheng S. Zhao W. Yu W. Xie H. Tong J. Jin H. Zhu X. Ye |
| author_facet | D. Zhou X. Huang X. Li L. Zhu M. Xie X. Huang L. Ma X. Yang J. Sun L. Li J. Zhu X. Zheng S. Zhao W. Yu W. Xie H. Tong J. Jin H. Zhu X. Ye |
| author_sort | D. Zhou |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:51:51Z |
| format | Article |
| id | doaj.art-37dcdd560a97401baebd7eca30c0b9a1 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:51:51Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-37dcdd560a97401baebd7eca30c0b9a12024-03-03T04:39:47ZengWileyHemaSphere2572-92412022-06-0161128112910.1097/01.HS9.0000847836.30971.66202206003-01128P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIALD. Zhou0X. Huang1X. Li2L. Zhu3M. Xie4X. Huang5L. Ma6X. Yang7J. Sun8L. Li9J. Zhu10X. Zheng11S. Zhao12W. Yu13W. Xie14H. Tong15J. Jin16H. Zhu17X. Ye181 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Chinahttp://journals.lww.com/10.1097/01.HS9.0000847836.30971.66 |
| spellingShingle | D. Zhou X. Huang X. Li L. Zhu M. Xie X. Huang L. Ma X. Yang J. Sun L. Li J. Zhu X. Zheng S. Zhao W. Yu W. Xie H. Tong J. Jin H. Zhu X. Ye P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL HemaSphere |
| title | P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL |
| title_full | P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL |
| title_fullStr | P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL |
| title_full_unstemmed | P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL |
| title_short | P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL |
| title_sort | p1243 ruxolitinib combined with dexamethasone in adult patients with newly diagnosed hemophagocytic lymphohistiocytosis interim analysis of a prospective single center single arm phase 2 clinical trial |
| url | http://journals.lww.com/10.1097/01.HS9.0000847836.30971.66 |
| work_keys_str_mv | AT dzhou p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT xhuang p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT xli p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT lzhu p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT mxie p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT xhuang p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT lma p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT xyang p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT jsun p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT lli p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT jzhu p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT xzheng p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT szhao p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT wyu p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT wxie p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT htong p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT jjin p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT hzhu p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial AT xye p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial |